Nuzenio

Stock Titan Vera

Stock Titan Vera entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 13 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Vera Therapeutics (VERA) ramps spending ahead of TRUTAKNA launch and posts $230.5M loss - Stock TitanStock Titan · Mon, 10 Aug 2026 20:11:44 GMTVera's TRUTAKNA Gets FDA Accelerated Approval for IgA Nephropathy - Stock TitanStock Titan · Mon, 10 Aug 2026 20:05:00 GMTSilence Therapeutics Plans Underwriters' Option: Up to 15% More Depositary Shares - Stock TitanStock Titan · Mon, 10 Aug 2026 20:01:00 GMTSilence Therapeutics trial cuts phlebotomies to 0.2 per patient - Stock TitanStock Titan · Mon, 10 Aug 2026 11:33:40 GMTSilence Therapeutics (SLN) halves net loss and boosts cash in Q2 2026 - Stock TitanStock Titan · Mon, 10 Aug 2026 11:20:49 GMTSilence Therapeutics Finishes Dosing 48 Patients in Blood Disorder Trial - Stock TitanStock Titan · Mon, 10 Aug 2026 11:15:00 GMTSilence Therapeutics to Discuss Divesiran Trial Results Aug. 10 - Stock TitanStock Titan · Sun, 09 Aug 2026 21:00:00 GMTState Street Corporation (VERA) discloses 4.1M-share stake in Vera Therapeutics - Stock TitanStock Titan · Fri, 07 Aug 2026 15:11:14 GMT

Timeline

Mon, 10 Aug 2026 20:11:44 GMTVera Therapeutics (VERA) ramps spending ahead of TRUTAKNA launch and posts $230.5M loss - Stock Titan
Mon, 10 Aug 2026 20:05:00 GMTVera's TRUTAKNA Gets FDA Accelerated Approval for IgA Nephropathy - Stock Titan
Mon, 10 Aug 2026 20:01:00 GMTSilence Therapeutics Plans Underwriters' Option: Up to 15% More Depositary Shares - Stock Titan
Mon, 10 Aug 2026 11:33:40 GMTSilence Therapeutics trial cuts phlebotomies to 0.2 per patient - Stock Titan
Mon, 10 Aug 2026 11:20:49 GMTSilence Therapeutics (SLN) halves net loss and boosts cash in Q2 2026 - Stock Titan
Mon, 10 Aug 2026 11:15:00 GMTSilence Therapeutics Finishes Dosing 48 Patients in Blood Disorder Trial - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Stock Titan Vera.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.